Mandatory national clinical audits as a tool to drive improvements in multiple sclerosis outcomes
Autor/innen
- Gavin Giovannoni
- Paola Zaratin
- Sara Samadzadeh
- Jelena Drulovic
- Laura Thomas
- Ruth Stross
- Anne Helme
- Saúl Reyes
- Tjalf Ziemssen
- Jeremy Hobart
Journal
- Multiple Sclerosis and Related Disorders
Quellenangabe
- Mult Scler Relat Disord 116: 108033
Zusammenfassung
Multiple sclerosis (MS) is a complex, time-critical neuroinflammatory condition where diagnostic delays and suboptimal treatment lead to irreversible disability. Despite an international consensus on best practices, equitable access to specialist care remains highly variable. We explore how implementing mandatory, continuous national clinical audit can potentially eradicate unwarranted clinical variation, drive systemic policy reform, secure targeted investment in specialist MS services, and create a positive feedback loop over time as services evolve. Drawing upon the highly successful models in stroke and cancer, we demonstrate how continuous, prospective data collection functions as an agent of change. We apply these mechanisms to MS care, using the internationally endorsed MS Brain Health: Time Matters policy recommendations, consensus quality standards, and their associated Quality Improvement tool as a blueprint for a potential mandatory national audit. Other recent initiatives, such as the Norwegian MS Registry, German implementation surveys and the UK MS Trust’s Generating Evidence in MS Services (GEMSS) programme, provide proof of concept that standardised measurement improves operational efficiency, reduces non-elective emergency admissions, and generates robust health economic data necessary for strategic MS-related healthcare commissioning. To ensure equitable, cost- effective care and unlock funding for multidisciplinary teams, healthcare systems should be encouraged to invest in the infrastructure required for mandatory, continuous national audits of MS and other brain health conditions.